Cost Benefit Analysis

Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia

Economics / Colombia / Cancer / Australia / Quality of life / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool

Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam

Public Health / Vietnam / Urban Health / Rural Health / Humans / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area

Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam

Public Health / Vietnam / Urban Health / Rural Health / Humans / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area

Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las guías europeas de prevención cardiovascular 2012

Diet / Public Health / Spain / Humans / Smoking Cessation / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention

Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012

Diet / Public Health / Spain / Humans / Smoking Cessation / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention

Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012

Diet / Public Health / Spain / Humans / Smoking Cessation / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention

Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock

Nursing / Cardiology / Treatment Outcome / Critical Care / Critical Care Medicine / Electrocardiography / Canada / Hypothermia / Humans / CS / Left Ventricular Assist Device / Female / Resuscitation / Male / Lung Diseases / Act / Refractory / Anesthesia / Perfusion / Clinical Sciences / Aged / Middle Aged / Adult / Surface Area / Public health systems and services research / Cost Benefit Analysis / Retrospective Studies / Prognosis / Chest / Intensive Care Medicine / Coronary Circulation / Centrifugal Pump / Hospital Mortality / Health Care Costs / Diabetic ketoacidosis / Lactic Acid / Logistic Models / Monte Carlo Method / Oxygenation / Thoracic and cardiovascular surgery / Heart Diseases / Extracorporeal Membrane Oxygenation / Assistive Device / Electrocardiography / Canada / Hypothermia / Humans / CS / Left Ventricular Assist Device / Female / Resuscitation / Male / Lung Diseases / Act / Refractory / Anesthesia / Perfusion / Clinical Sciences / Aged / Middle Aged / Adult / Surface Area / Public health systems and services research / Cost Benefit Analysis / Retrospective Studies / Prognosis / Chest / Intensive Care Medicine / Coronary Circulation / Centrifugal Pump / Hospital Mortality / Health Care Costs / Diabetic ketoacidosis / Lactic Acid / Logistic Models / Monte Carlo Method / Oxygenation / Thoracic and cardiovascular surgery / Heart Diseases / Extracorporeal Membrane Oxygenation / Assistive Device

Organización Nacional de Trasplante de Venezuela: a new initiative to approach donation and transplantation in our country

Health Education / Venezuela / Adolescent / Nonprofit Organizations / Humans / Program Development / Female / Organ Transplantation / Male / Attitude / Aged / Middle Aged / Adult / Cost Benefit Analysis / Program Development / Female / Organ Transplantation / Male / Attitude / Aged / Middle Aged / Adult / Cost Benefit Analysis

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
Copyright © 2017 DATOSPDF Inc.